Article
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
1 Apr 2008
Abstract excerpt
The arrival of new antiviral drugs to treat chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections has given rise to great expectations along with concerns regarding the selection of drug-resistant variants. Many lessons learnt from HIV therapeutics can be helpful for designing adequate treatment strategies against viral hepatitis, the avoidance of sequential weak monotherapies being one of them....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
